Survival Trends in Patients With Gastric and Esophageal Adenocarcinomas: A Population-Based Study
作者： Sarah J. Crane , G. Richard Locke , William S. Harmsen , Alan R. Zinsmeister , Yvonne Romero
DOI: 10.4065/83.10.1087
关键词:
摘要: OBJECTIVE To use a population-based approach to describe survival trends in patients diagnosed as having gastric or esophageal adenocarcinoma. PATIENTS AND METHODS A complete chart review of all inpatient and outpatient records, using the resources Rochester Epidemiology Project, was conducted Olmsted County, Minnesota (population 124,277), primarily rural county with one large urban area. All residents County who were adenocarcinoma from January 1, 1971, through December 31, 2000, included study. The main outcomes median 2-year 5-year rates, by decade diagnosis. RESULTS From 1971 for (n=121) decreased 5.5 months 3.2 months, whereas (n=65) increased 8.5 11.7 months. Decade diagnosis not significantly associated patient either ( P >.05). There no significant shift stage disease at during 30-year period CONCLUSION No change has occurred rates this population adenocarcinoma, which is representative US white population.
mayoclinicproceedings.org
elsevier.com
sci-hub.se 参考文章(30)
Cynthia Levy, Paul Angulo, Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis. The American Journal of Gastroenterology. ,vol. 99, pp. 269- 270 ,(2004) , 10.1111/J.1572-0241.2004.04094.X
S. J. CRANE, G. RICHARD LOCKE, W. S. HARMSEN, N. N. DIEHL, A. R. ZINSMEISTER, L. JOSEPH MELTON, Y. ROMERO, N. J. TALLEY, The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Alimentary Pharmacology & Therapeutics. ,vol. 25, pp. 447- 453 ,(2006) , 10.1111/J.1365-2036.2006.03229.X
Manuel Pera, Alan J. Cameron, Victor F. Trastek, Herschel A. Carpenter, Alan R. Zinsmeister, Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction Gastroenterology. ,vol. 104, pp. 510- 513 ,(1993) , 10.1016/0016-5085(93)90420-H
Manish A. Shah, David P. Kelsen, Combined modality therapy of esophageal cancer: changes in the standard of care? Annals of Surgical Oncology. ,vol. 11, pp. 641- 643 ,(2004) , 10.1245/ASO.2004.04.907
T D L Crosby, A E Brewster, A Borley, L Perschky, P Kehagioglou, J Court, T S Maughan, Definitive chemoradiation in patients with inoperable oesophageal carcinoma. British Journal of Cancer. ,vol. 90, pp. 70- 75 ,(2004) , 10.1038/SJ.BJC.6601461
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
Seamus J. Murphy, William Dickey, Dermot Hughes, Frank A. O??Connor, Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland. European Journal of Gastroenterology & Hepatology. ,vol. 17, pp. 1029- 1035 ,(2005) , 10.1097/00042737-200510000-00005
G.Richard Locke, Nicholas J. Talley, Herschel A. Carpenter, William S. Harmsen, Alan R. Zinsmeister, L.Joseph Melton, Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period Gastroenterology. ,vol. 109, pp. 1750- 1756 ,(1995) , 10.1016/0016-5085(95)90740-8
A. Newnham, M. J. Quinn, P. Babb, J. Y. Kang, A. Majeed, Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971–1998/1999 Alimentary Pharmacology & Therapeutics. ,vol. 17, pp. 655- 664 ,(2003) , 10.1046/J.1365-2036.2003.01520.X
Linda Morris Brown, Susan S Devesa, Epidemiologic trends in esophageal and gastric cancer in the United States Surgical Oncology Clinics of North America. ,vol. 11, pp. 235- 256 ,(2002) , 10.1016/S1055-3207(02)00002-9